Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: BRAINSTORM CELL THERAPEUTICS INC.
CIK: 1137883
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-09-07
Last Filing Date: 2025-03-31
SEC Filings
Start End Frame Filed ACCN Value View
2017-01-01 2017-12-31 CY2016 2018-03-08 0001144204-18-013470 $ 18,777,348 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-13 0001144204-15-048801 $ 18,450,464 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-16 0001144204-15-066028 $ 18,480,957 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-11 0001144204-16-118186 $ 18,654,040 View
2016-07-01 2016-09-30 CY2015Q3 2016-11-14 0001144204-16-134410 $ 18,656,615 View
2017-04-01 2017-06-30 CY2016Q2 2017-08-14 0001144204-17-043149 $ 18,738,496 View
2017-07-01 2017-09-30 CY2016Q3 2017-10-17 0001144204-17-052741 $ 18,783,997 View
2023-01-01 2023-12-31 CY2022Q4I 2024-04-01 0001410578-24-000385 $ 185,000 View
2016-01-01 2016-03-31 CY2015Q1 2016-05-10 0001144204-16-100124 $ 18,653,804 View
2016-01-01 2016-12-31 CY2015 2017-03-29 0001144204-17-017265 $ 18,663,162 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-15 0001144204-17-027041 $ 18,688,377 View
2018-01-01 2018-03-31 CY2017Q1 2018-05-14 0001144204-18-027804 $ 19,047,350 View
2018-04-01 2018-06-30 CY2017Q2 2018-07-23 0001144204-18-039198 $ 19,505,157 View
2018-07-01 2018-09-30 CY2017Q3 2018-10-29 0001144204-18-055650 $ 20,691,900 View
2018-01-01 2018-12-31 None 2019-03-29 0001144204-19-017041 $ 19,997,710 View
2018-01-01 2018-12-31 CY2017 2019-04-01 0001144204-19-017368 $ 19,997,710 View
2019-01-01 2019-03-31 CY2018Q1 2019-05-10 0001144204-19-025310 $ 20,917,329 View
2019-04-01 2019-06-30 CY2018Q2 2019-08-13 0001144204-19-039284 $ 21,703,001 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-14 0001104659-19-063577 $ 22,254,993 View
2019-01-01 2019-12-31 CY2018 2020-02-18 0001104659-20-022244 $ 21,906,257 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-07 0001104659-20-057690 $ 28,423,837 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-05 0001104659-20-090549 $ 29,274,130 View
2020-07-01 2020-09-30 CY2020Q3 2020-10-15 0001104659-20-115097 $ 31,154,101 View
2020-01-01 2020-12-31 CY2020 2021-02-04 0001104659-21-011928 $ 29,848,217 View
2011-01-01 2011-06-30 CY2011Q2I 2011-09-07 0001144204-11-051620 $ 80,000 View
2011-01-01 2011-09-30 CY2011Q3I 2011-11-14 0001144204-11-064186 $ 228,000 View
2011-01-01 2011-12-31 CY2011 2012-03-15 0001144204-12-015305 $ 243,000 View
2012-01-01 2012-03-31 CY2012Q1 2012-05-11 0001144204-12-028107 $ 20,000 View
2021-01-01 2021-03-31 CY2021Q1 2021-04-26 0001104659-21-054692 $ 35,791,309 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-05 0001104659-21-100414 $ 36,318,561 View
2012-04-01 2012-06-30 CY2011Q2 2012-08-29 0001144204-12-048515 $ 128,078,347 View
2012-07-01 2012-09-30 CY2011Q3 2012-11-13 0001144204-12-061201 $ 145,407,840 View
2012-01-01 2012-12-31 CY2011 2013-03-14 0001144204-13-014932 $ 137,596,391 View
2013-01-01 2013-03-31 CY2012Q1 2013-05-09 0001144204-13-027214 $ 150,953,117 View
2015-01-01 2015-12-31 CY2014 2016-03-09 0001144204-16-086932 $ 18,405,610 View
2021-07-01 2021-09-30 CY2020Q3 2021-11-15 0001104659-21-138505 $ 36,304,878 View
2021-01-01 2021-12-31 CY2020 2022-03-28 0001410578-22-000554 $ -1,717,000 View
2022-01-01 2022-03-31 CY2022Q1 2022-05-16 0001410578-22-001572 $ 4 View
2022-01-01 2022-06-30 CY2022Q2I 2022-08-15 0001410578-22-002510 $ 4 View
2023-04-01 2023-06-30 CY2023Q2I 2023-08-14 0001410578-23-001831 $ 22,000 View
2022-01-01 2022-09-30 CY2022Q3I 2022-11-14 0001410578-22-003271 $ 36,000 View
2021-01-01 2021-12-31 CY2021 2023-03-30 0001410578-23-000426 $ 35,000 View
2023-01-01 2023-03-31 CY2023Q1 2023-05-15 0001410578-23-001157 $ 4 View
2023-07-01 2023-09-30 CY2023Q3I 2023-11-14 0001410578-23-002443 $ 358,000 View
2013-04-01 2013-06-30 CY2012Q2 2013-08-14 0001144204-13-045716 $ 152,546,703 View
2013-07-01 2013-09-30 CY2012Q3 2013-11-14 0001144204-13-061876 $ 164,223,127 View
2013-01-01 2013-12-31 CY2012 2014-03-27 0001144204-14-018114 $ 161,071,968 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-13 0001144204-14-029919 $ 176,305,587 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-12 0001144204-14-048755 $ 186,253,752 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-13 0001144204-14-067525 $ 15,158,411 View
2014-01-01 2014-12-31 CY2013 2015-03-26 0001144204-15-018682 $ 13,662,758 View
2015-01-01 2015-03-31 CY2014Q1 2015-05-14 0001144204-15-030742 $ 18,128,440 View
2024-01-01 2024-03-31 CY2024Q1I 2024-05-14 0001410578-24-000820 $ 182,000 View
2024-04-01 2024-04-25 CY2024Q2I 2024-08-14 0001410578-24-001400 $ 2 View
2024-01-01 2024-09-30 CY2024Q1I 2024-11-14 0001410578-24-002000 $ 0 View
2024-01-01 2024-12-31 CY2024 2025-03-31 0001410578-25-000545 $ 52,000 View
SEC Facts By Type
Type Name Description View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Accounts Payable, Other, Current Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
invest Investment Options, Exercise Price Exercise price of the option. View
invest Investment Warrants, Exercise Price Exercise price of the warrants. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. View
us-gaap Cash Provided by (Used in) Financing Activities, Discontinued Operations Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Cash Provided by (Used in) Investing Activities, Discontinued Operations Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Cash Provided by (Used in) Operating Activities, Discontinued Operations Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Deferred Compensation Arrangement with Individual, Exercise Price The per share price that the individual must pay to acquire shares under the deferred compensation arrangement. View
us-gaap Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Grants Receivable Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. View
us-gaap Grants Receivable, Current Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Amount after tax of income (loss) from continuing operations attributable to the parent. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Domestic The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Foreign The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile. View
us-gaap Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. View
us-gaap Income (Loss) from Continuing Operations, Per Basic and Diluted Share The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. View
us-gaap Income (Loss) from Continuing Operations, Per Basic Share The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. View
us-gaap Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Increase (Decrease) in Due from Officers and Stockholders, Current The increase (decrease) during the reporting period in current receivables (due within one year or one operating cycle) to be collected from the reporting entity's executives and owners. View
us-gaap Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. View
us-gaap 1607952 None View
us-gaap Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Restricted Cash The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Lease, Cost Amount of lease cost recognized by lessee for lease contract. View
us-gaap Lessee, Operating Lease, Liability, to be Paid Amount of lessee's undiscounted obligation for lease payment for operating lease. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year One Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Five Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Four Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Three Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year Two Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. View
us-gaap Lessee, Operating Lease, Liability, Undiscounted Excess Amount Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer. View
us-gaap Long-term Investments The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Nontrade Receivables, Current The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Lease, Expense Amount of operating lease expense. Excludes sublease income. View
us-gaap Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease. View
us-gaap Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. View
us-gaap Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. View
us-gaap Operating Lease, Payments Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. View
us-gaap Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease. View
us-gaap Operating Leases, Future Minimum Payments Due Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Five Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Four Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Three Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Remainder of Fiscal Year Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate for operating lease calculated at point in time. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Depreciation and Amortization Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Liability, Other Postretirement Defined Benefit Plan, Noncurrent Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan. View
us-gaap Payments for (Proceeds from) Investments The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets. View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Payments for Repurchase of Warrants The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Payments to Acquire Short-term Investments The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. View
us-gaap Prepaid Expense and Other Assets Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. View
us-gaap Prepaid Expense, Noncurrent Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. View
us-gaap Proceeds from Grantors Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. View
us-gaap Proceeds from Issuance of Long-term Debt and Capital Securities, Net The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c). View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from (Repayments of) Bank Overdrafts The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Related Party Transaction, Amounts of Transaction Amount of transactions with related party during the financial reporting period. View
us-gaap Repayments of Other Short-term Debt Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer. View
us-gaap Research and Development Arrangement, Contract to Perform for Others, Compensation Earned The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Severance Costs (Deprecated 2013-01-31) The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination or a discontinued operation as defined by generally accepted accounting principles and costs associated with one-time termination benefits. View
us-gaap Severance Costs Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Number of shares related to Restricted Stock Award forfeited during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued The number of shares or units of entity securities issued in the transaction in which equity securities were issued to pay for goods or nonemployee services. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury. View
us-gaap Short-term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. View
us-gaap Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) Value of shares issued as consideration for cash for development stage entities. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Purchase of Assets Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Stock or Unit Option Plan Expense Amount of noncash expense for option under share-based payment arrangement. View
us-gaap Stock Redeemed or Called During Period, Value Equity impact of the value of stock bought back by the entity at the exercise price or redemption price. View
us-gaap Tax Credit Carryforward, Amount The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Prepaid Expense and Other Assets, Noncurrent Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer. View
us-gaap Prepaid Rent Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer. View
us-gaap Deposits Assets, Current Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Restricted Cash, Noncurrent Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. View
us-gaap Loss Contingency, Number of Defendants Number of defendants named in a legal action. View
us-gaap Stockholders' Equity Note, Stock Split, Conversion Ratio Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. View
us-gaap Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. View
us-gaap Payments for (Proceeds from) Productive Assets The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Income (Loss) from Continuing Operations, Per Diluted Share The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Cash, Cash Equivalents, and Short-term Investments Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Instrument, Convertible, Beneficial Conversion Feature Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. View
us-gaap Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) The increase (decrease) during the period, which was recognized in earnings, in the unrealized gains or losses on derivative instruments that are not or are no longer designated as hedging instruments. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Operating Loss Carryforwards, Valuation Allowance The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Payments for (Proceeds from) Short-term Investments The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Value Added Tax Receivable, Current Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. View
us-gaap Number of Reportable Segments Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. View
us-gaap Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. View
Chart of Accounts => Accounts
Name View
Grants Receivable View
Grants Receivable, Current View
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent View
Income (Loss) from Continuing Operations before Income Taxes, Domestic View
Accounts Payable, Current View
Accounts Payable, Other, Current View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accrued Liabilities, Current View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Adjustments to Additional Paid in Capital, Other View
Amortization of Debt Discount (Premium) View
Assets View
Assets, Current View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, and Short-term Investments View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash Provided by (Used in) Financing Activities, Discontinued Operations View
Cash Provided by (Used in) Investing Activities, Discontinued Operations View
Cash Provided by (Used in) Operating Activities, Discontinued Operations View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Outstanding View
Commitments and Contingencies View
Common Stock, Capital Shares Reserved for Future Issuance View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Conversion of Stock, Amount Converted View
Convertible Notes Payable View
Convertible Notes Payable, Current View
Deferred Compensation Arrangement with Individual, Exercise Price View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net View
Deferred Tax Assets, Valuation Allowance View
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs View
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay View
Depreciation View
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Fair Value Adjustment of Warrants View
General and Administrative Expense View
Income (Loss) from Continuing Operations, Per Basic and Diluted Share View
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent View
Income Tax Expense (Benefit) View
Increase (Decrease) in Accounts Payable, Trade View
Increase (Decrease) in Due from Officers and Stockholders, Current View
Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) View
Increase (Decrease) in Interest Payable, Net View
1594032 View
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Restricted Cash View
Interest Expense View
Issuance of Stock and Warrants for Services or Claims View
Lease, Cost View
Lessee, Operating Lease, Liability, to be Paid View
Lessee, Operating Lease, Liability, to be Paid, Year One View
Lessee, Operating Lease, Liability, to be Paid, Year Five View
Lessee, Operating Lease, Liability, to be Paid, Year Four View
Lessee, Operating Lease, Liability, to be Paid, Year Three View
Lessee, Operating Lease, Liability, to be Paid, Year Two View
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year View
Lessee, Operating Lease, Liability, Undiscounted Excess Amount View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Liabilities, Noncurrent View
Long-term Investments View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Nontrade Receivables, Current View
Operating Expenses View
Operating Income (Loss) View
Operating Lease, Expense View
Operating Lease, Liability View
Operating Lease, Liability, Current View
Operating Lease, Liability, Noncurrent View
Operating Lease, Payments View
Operating Lease, Right-of-Use Asset View
Operating Leases, Future Minimum Payments Due View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Operating Leases, Future Minimum Payments, Due in Five Years View
Operating Leases, Future Minimum Payments, Due in Four Years View
Operating Leases, Future Minimum Payments, Due in Three Years View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Leases, Future Minimum Payments, Remainder of Fiscal Year View
Operating Lease, Weighted Average Discount Rate, Percent View
Operating Loss Carryforwards View
Operating Loss Carryforwards, Valuation Allowance View
Other Assets, Noncurrent View
Other Depreciation and Amortization View
Other Nonoperating Income View
Liability, Other Postretirement Defined Benefit Plan, Noncurrent View
Payments for (Proceeds from) Investments View
Payments for (Proceeds from) Short-term Investments View
Payments for Repurchase of Common Stock View
Payments for Repurchase of Warrants View
Payments to Acquire Short-term Investments View
Prepaid Expense and Other Assets View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Prepaid Expense View
Prepaid Expense, Noncurrent View
Proceeds from Grantors View
Proceeds from Issuance Initial Public Offering View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Debt View
Proceeds from Issuance of Long-term Debt and Capital Securities, Net View
Proceeds from Issuance of Warrants View
Proceeds from Issuance or Sale of Equity View
Proceeds from (Repayments of) Bank Overdrafts View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Gross View
Property, Plant and Equipment, Net View
Related Party Transaction, Amounts of Transaction View
Repayments of Other Short-term Debt View
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability View
Sale of Stock, Price Per Share View
Severance Costs (Deprecated 2013-01-31) View
Severance Costs View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued View
Share Price View
Shares, Outstanding View
Short-term Investments View
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture View
Stockholders' Equity Attributable to Parent View
Stock Issued View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Purchase of Assets View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Stock Issued During Period, Value, Stock Options Exercised View
Stock or Unit Option Plan Expense View
Stock Redeemed or Called During Period, Value View
Stock Repurchased During Period, Value View
Tax Credit Carryforward, Amount View
Treasury Stock, Common, Value View
Weighted Average Number of Shares Outstanding, Basic View
Earnings Per Share, Basic View
Earnings Per Share, Diluted View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Increase (Decrease) in Accounts Payable View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value View
Prepaid Expense and Other Assets, Noncurrent View
Prepaid Rent View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value View
Proceeds from Issuance of Private Placement View
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent View
Deposits Assets, Current View
Employee-related Liabilities, Current View
Increase (Decrease) in Accrued Liabilities View
Restricted Cash, Noncurrent View
Loss Contingency, Number of Defendants View
Stockholders' Equity Note, Stock Split, Conversion Ratio View
Other Liabilities, Current View
Number of Reportable Segments View
Additional Paid in Capital, Common Stock View
Debt Conversion, Converted Instrument, Amount View
Debt Instrument, Convertible, Beneficial Conversion Feature View
Income (Loss) from Continuing Operations before Income Taxes, Foreign View
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest View
Income (Loss) from Continuing Operations, Per Basic Share View
Income (Loss) from Continuing Operations, Per Diluted Share View
Payments to Acquire Property, Plant, and Equipment View
Proceeds from Stock Options Exercised View
Proceeds from Warrant Exercises View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Value Added Tax Receivable, Current View
Warrants and Rights Outstanding View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Payments for (Proceeds from) Productive Assets View
Stock Issued During Period, Value, Issued for Services View